EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland

Miika Kujanpää, Ville Vuollo, Antti Tiisanoja, Marja-Liisa Laitala, Jussi Koivunen, George K Sándor, Saujanya Karki

Clinical Oral Investigations · 2026

DOI: 10.1007/s00784-026-07171-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Investigations, 2026. Verfasst von Miika Kujanpää und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Population Health, University of Oulu, Aapistie 3, POB 5281, Oulu, FI- 90220, Finland. miika.kujanpaa@student.oulu.fi. Hauptthemen laut MEDLINE: Breast Neoplasms, Bone Density Conservation Agents, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suomen Hammaslääkäriseura Apollonia, Oulun Yliopiston Tukisäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study evaluated the incidence of MRONJ and associated factors among breast cancer patients with bone metastases in Finland. Materials and methods This retrospective cohort study included all adult patients with breast cancer and bone metastases who were prescribed antiresorptive therapy between 2013 and 2015. Patients were identified from national health care registers and followed through 2020. The outcome variable was MRONJ (M87.1). Covariates included age, oral diseases, dental procedures, type of antiresorptive (AR) prescribed, comorbidities, and concomitant medications.

Results

A total of 652 patients met the inclusion criteria. The incidence of MRONJ ranged from 0% to 2.2% among bisphosphonate users, compared with 12.6% among denosumab users and 15.3% among patients receiving sequential bisphosphonate and denosumab therapy. Both denosumab monotherapy and sequential bisphosphonate-denosumab therapy were associated with substantially increased MRONJ risk compared with bisphosphonate therapy.

Conclusions

Denosumab use and infection-related invasive dental procedures showed the strongest associations with MRONJ in this study population. Clinical relevance MRONJ incidence differed by type of antiresorptive therapy, with higher occurrence among patients using denosumab or bisphoshonates followed by denosumab compared with bisphosphonates. MRONJ was more frequent among patients who underwent infection-related invasive dental procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBone Density Conservation AgentsBisphosphonate-Associated Osteonecrosis of the JawBone NeoplasmsHumansFinlandFemaleIncidenceRetrospective StudiesAgedMiddle AgedRisk FactorsRegistriesDenosumabAdultDiphosphonatesAged, 80 and over

Stichwörter der Autor:innen

BisphosphonatesBreast cancerDenosumabMRONJOsteonecrosis

Substanzen

Bone Density Conservation AgentsDenosumabDiphosphonates

Autor:innen und Institutionen

  • Research Unit of Population Health, University of Oulu, Aapistie 3, POB 5281, Oulu, FI- 90220, Finland. miika.kujanpaa@student.oulu.fi.
  • Research Unit of Population Health, University of Oulu, Aapistie 3, POB 5281, Oulu, FI- 90220, Finland.
  • The Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
  • Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.
  • Medical Research Center Oulu, Oulu, Finland.

Förderung

  • Suomen Hammaslääkäriseura Apollonia
  • Oulun Yliopiston Tukisäätiö

Zitieren

APA

Kujanpää, M., Vuollo, V., Tiisanoja, A., Laitala, M. L., Koivunen, J., Sándor, G. K., & Karki, S. (2026). Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland. Clinical Oral Investigations. https://doi.org/10.1007/s00784-026-07171-5

Vancouver

Kujanpää M, Vuollo V, Tiisanoja A, Laitala ML, Koivunen J, Sándor GK, et al. Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland. Clinical Oral Investigations. 2026. doi:10.1007/s00784-026-07171-5

BibTeX
@article{Kujanp2026,
  author = {Kujanpää, Miika and Vuollo, Ville and Tiisanoja, Antti and Laitala, Marja-Liisa and Koivunen, Jussi and Sándor, George K and Karki, Saujanya},
  title = {Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland},
  journal = {Clinical Oral Investigations},
  year = {2026},
  doi = {10.1007/s00784-026-07171-5}
}
Kostenlos starten →